SI
CRL icon

Stephens Inc’s Charles River Laboratories CRL Stock Holding History

Stephens Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,607
Closed -$242K – 1288
2025
Q1 		$242K Sell
1,607
-2,603
-62% -$436K ﹤0.01% 1073
2024
Q4 		$777K Sell
4,210
-1,253
-23% -$241K 0.01% 672
2024
Q3 		$1.08M Buy
5,463
+3,055
+127% +$635K 0.02% 590
2024
Q2 		$497K Buy
2,408
+79
+3% +$17.9K 0.01% 800
2024
Q1 		$631K Buy
2,329
+373
+19% +$89.1K 0.01% 721
2023
Q4 		$462K Buy
1,956
+93
+5% +$18.3K 0.01% 773
2023
Q3 		$365K Buy
1,863
+32
+2% +$6.57K 0.01% 838
2023
Q2 		$385K Buy
1,831
+60
+3% +$11.9K 0.01% 837
2023
Q1 		$357K Buy
1,771
+234
+15% +$53K 0.01% 818
2022
Q4 		$335K Sell
1,537
-152
-9% -$33.2K 0.01% 829
2022
Q3 		$332K Sell
1,689
-228
-12% -$49.2K 0.01% 860
2022
Q2 		$410K Buy
1,917
+178
+10% +$43.5K 0.01% 800
2022
Q1 		$494K Sell
1,739
-60
-3% -$18.5K 0.01% 810
2021
Q4 		$678K Buy
1,799
+1,303
+263% +$506K 0.01% 754
2021
Q3 		$205K Buy
+496
New +$206K ﹤0.01% 1206

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Stephens Inc's CRL Position: Q2 2025 in Review

Stephens Inc sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 1,607 shares — an estimated $242K sold.

Stephens Inc first reported a position in CRL in Q3 2021 and held it in 15 quarters. The position peaked at $1.08M in Q3 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Stephens Inc reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Stephens Inc sold 1,607 Charles River Laboratories shares in Q2 2025, an estimated $242K.
  • Stephens Inc first reported a position in Charles River Laboratories in Q3 2021 and held it in 15 quarters.
  • Stephens Inc's Charles River Laboratories position peaked at $1.08M in Q3 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Stephens Inc's 13F filing for Q2 2025, filed 29 Jul 2025.